The International Association for the Study of Lung Cancer (IASLC) is a leading global organization dedicated to advancing research, education, and advocacy in thoracic oncology. Celebrating its 50th anniversary in 2024, IASLC plays a pivotal role in shaping the standards of care for lung cancer through its various initiatives and events, such as the prominent World Conference on Lung Cancer (WCLC). The organization focuses on a range of crucial topics including diagnostic oncology, early detection, risk assessment, and evolving standards of care.

IASLC emphasizes collaboration among healthcare professionals, offering resources and support across multiple disciplines such as radiation oncology, nursing, and patient advocacy. Their commitment to improving treatment and care for patients is evident in their promotion of clinical trials and innovative therapies, including groundbreaking studies on non-small cell lung cancer and new strategies for tobacco cessation. Through educational symposia and a robust news platform, IASLC ensures that practitioners stay informed on the latest advances and regulatory approvals in the field.